Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial by Boorjian, Stephen A, Prof, Alemozaffar, Mehrdad, MD, Konety, Badrinath R, Prof, Shore, Neal D, MD, Gomella, Leonard G, Prof, Kamat, Ashish M, Prof, Bivalacqua, Trinity J, Prof, Montgomery, Jeffrey S, Prof, Lerner, Seth P, Prof, Busby, Joseph E, MD, Poch, Michael, MD, Crispen, Paul L, MD, Steinberg, Gary D, Prof, Schuckman, Anne K, MD, Downs, Tracy M, Prof, Svatek, Robert S, Prof, Mashni, Joseph, MD, Lane, Brian R, MD, Guzzo, Thomas J, Prof, Bratslavsky, Gennady, Prof, Karsh, Lawrence I, MD, Woods, Michael E, MD, Brown, Gordon, DO, Canter, Daniel, MD, Luchey, Adam, MD, Lotan, Yair, Prof, Krupski, Tracey, MD, Inman, Brant A, MD, Williams, Michael B, MD, Cookson, Michael S, Prof, Keegan, Kirk A, MD, Andriole, Gerald L, Prof, Sankin, Alexander I, MD, Boyd, Alan, Prof, O'Donnell, Michael A, Prof, Sawutz, David, PhD, Philipson, Richard, MD, Coll, Ruth, BSc, Narayan, Vikram M, MD, Treasure, F Peter, PhD, Yla-Herttuala, Seppo, Prof, Parker, Nigel R, PhD, Dinney, Colin P N, Prof

Get full text